Mindset Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
7,694
+363
+5% +$78.1K 0.37% 26
2026
Q1
$1.59M Sell
7,331
-29
-0.4% -$6.43K 0.43% 27
2025
Q4
$1.68M Buy
7,360
+194
+3% +$44.2K 0.44% 23
2025
Q3
$1.66M Buy
7,166
+272
+4% +$55.4K 0.45% 20
2025
Q2
$1.28M Buy
6,894
+145
+2% +$26.9K 0.42% 22
2025
Q1
$1.41M Buy
6,749
+678
+11% +$132K 0.55% 17
2024
Q4
$1.08M Buy
6,071
+69
+1% +$12.7K 0.39% 18
2024
Q3
$1.19M Buy
+6,002
New +$1.12M 0.49% 15

Other funds holding ABBV

Mindset Wealth Management's ABBV Position: Q2 2026 in Review

Mindset Wealth Management increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $78.1K and bringing the position to 7,694 shares worth $1.94M. The position accounts for 0.37% of the portfolio, ranked #26.

Mindset Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mindset Wealth Management held 7,694 shares of AbbVie worth $1.94M as of Q2 2026.
  • Mindset Wealth Management bought 363 AbbVie shares in Q2 2026, an estimated $78.1K.
  • AbbVie made up 0.37% of Mindset Wealth Management's portfolio in Q2 2026, its #26 holding.
  • Mindset Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mindset Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.